| Denosumab treatment for fibrous dysplasia AM Boyce, WH Chong, J Yao, RI Gafni, MH Kelly, CE Chamberlain, ... Journal of Bone and Mineral Research 27 (7), 1462-1470, 2012 | 180 | 2012 |
| Fibrous dysplasia/mccune-albright syndrome AM Boyce, P Florenzano, LF de Castro, MT Collins GeneReviews®[Internet], 2019 | 118 | 2019 |
| Acromegaly and mccune-albright syndrome S Salenave, AM Boyce, MT Collins, P Chanson The Journal of Clinical Endocrinology & Metabolism 99 (6), 1955-1969, 2014 | 103 | 2014 |
| Tumor localization and biochemical response to cure in tumor‐induced osteomalacia WH Chong, P Andreopoulou, CC Chen, J Reynolds, L Guthrie, M Kelly, ... Journal of Bone and Mineral Research 28 (6), 1386-1398, 2013 | 96 | 2013 |
| Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia YH Lim, D Ovejero, JS Sugarman, CMC DeKlotz, A Maruri, LF Eichenfield, ... Human molecular genetics 23 (2), 397-407, 2014 | 89 | 2014 |
| Rare bone diseases and their dental, oral, and craniofacial manifestations BL Foster, MS Ramnitz, RI Gafni, AB Burke, AM Boyce, JS Lee, JT Wright, ... Journal of dental research 93 (7_suppl), 7S-19S, 2014 | 87 | 2014 |
| Limb-girdle muscular dystrophy overview E Pegoraro, EP Hoffman | 82* | 2012 |
| Fibrous dysplasia/McCune-Albright syndrome: clinical and translational perspectives C Robinson, MT Collins, AM Boyce Current osteoporosis reports 14 (5), 178-186, 2016 | 81 | 2016 |
| A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone AM Boyce, MH Kelly, BA Brillante, H Kushner, S Wientroub, M Riminucci, ... The Journal of Clinical Endocrinology & Metabolism 99 (11), 4133-4140, 2014 | 80 | 2014 |
| Characterization and management of testicular pathology in McCune-Albright syndrome AM Boyce, WH Chong, TH Shawker, PA Pinto, WM Linehan, ... The Journal of Clinical Endocrinology & Metabolism 97 (9), E1782-E1790, 2012 | 66 | 2012 |
| Fibrous dysplasia of bone: craniofacial and dental implications AB Burke, MT Collins, AM Boyce Oral diseases 23 (6), 697-708, 2017 | 60 | 2017 |
| Denosumab: an emerging therapy in pediatric bone disorders AM Boyce Current osteoporosis reports 15 (4), 283-292, 2017 | 58 | 2017 |
| Approach to the child with fractures AM Boyce, RI Gafni The Journal of Clinical Endocrinology & Metabolism 96 (7), 1943-1952, 2011 | 57 | 2011 |
| Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess AM Boyce, MK Glover, MH Kelly, BA Brillante, JA Butman, EJ Fitzgibbon, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E126-E134, 2013 | 55 | 2013 |
| Neuroendocrine ACTH-producing tumor of the thymus—experience with 12 patients over 25 years NM Neary, A Lopez-Chavez, BS Abel, AM Boyce, N Schaub, K Kwong, ... The Journal of Clinical Endocrinology & Metabolism 97 (7), 2223-2230, 2012 | 55 | 2012 |
| Dental perspectives in fibrous dysplasia and McCune–Albright syndrome SO Akintoye, AM Boyce, MT Collins Oral surgery, oral medicine, oral pathology and oral radiology 116 (3), e149 …, 2013 | 47 | 2013 |
| Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium MK Javaid, A Boyce, N Appelman-Dijkstra, J Ong, P Defabianis, A Offiah, ... Orphanet journal of rare diseases 14 (1), 1-17, 2019 | 46 | 2019 |
| Effects of denosumab treatment and discontinuation on human growth plates HD Wang, AM Boyce, JY Tsai, RI Gafni, FA Farley, JZ Kasa-Vubu, ... The Journal of Clinical Endocrinology & Metabolism 99 (3), 891-897, 2014 | 46 | 2014 |
| Bone-grafting in polyostotic fibrous dysplasia AI Leet, AM Boyce, KA Ibrahim, S Wientroub, H Kushner, MT Collins The Journal of bone and joint surgery. American volume 98 (3), 211, 2016 | 42 | 2016 |
| Bisphosphonate treatment for children with disabling conditions AM Boyce, LL Tosi, SM Paul PM&R 6 (5), 427-436, 2014 | 39 | 2014 |
